Indications Discovery Preclinical Phase 1 Phase 2 Phase 3

Validive®

Radiation induced SOM in OPC

Phase 2b/3 ready Phase 2b/3 ready

Discovery complete

Phase 2b/3 ready

Phase 2b/3 ready Phase 2b/3 ready

Preclinical complete

Phase 2b/3 ready

Phase 2b/3 ready Phase 2b/3 ready

Phase 1 complete

Phase 2b/3 ready

Phase 2b/3 ready Phase 2b/3 ready

Phase 2 in progress

Phase 2b/3 ready

Phase 2b/3 ready Phase 2b/3 ready

Phase 3 not started

Phase 2b/3 ready

Indications Discovery Preclinical Phase 1 Phase 2 Phase 3

Camsirubicin (MNPR-201)

Advanced Soft Tissue Sarcoma

Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2 Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2

Discovery complete

Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2

Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2 Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2

Preclinical complete

Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2

Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2 Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2

Phase 1 complete

Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2

Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2 Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2

Phase 2 in progress

Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2

Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2 Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2

Phase 3 not started

Phase 2 Data in Soft Tissue Sarcoma, Collaboration with GEIS for larger Phase 2

Indications Discovery Preclinical Phase 1 Phase 2 Phase 3

MNPR-101

Severe COVID-19

In Collaboration with NorthStar Medical Radioisotopes In Collaboration with NorthStar Medical Radioisotopes

Discovery in progress

In Collaboration with NorthStar Medical Radioisotopes

In Collaboration with NorthStar Medical Radioisotopes In Collaboration with NorthStar Medical Radioisotopes

Preclinical not started

In Collaboration with NorthStar Medical Radioisotopes

In Collaboration with NorthStar Medical Radioisotopes In Collaboration with NorthStar Medical Radioisotopes

Phase 1 not started

In Collaboration with NorthStar Medical Radioisotopes

In Collaboration with NorthStar Medical Radioisotopes In Collaboration with NorthStar Medical Radioisotopes

Phase 2 not started

In Collaboration with NorthStar Medical Radioisotopes

In Collaboration with NorthStar Medical Radioisotopes In Collaboration with NorthStar Medical Radioisotopes

Phase 3 not started

In Collaboration with NorthStar Medical Radioisotopes

Indications Discovery Preclinical Phase 1 Phase 2 Phase 3

MNPR-101

Advanced Solid Cancers

Pre-IND Pre-IND

Discovery complete

Pre-IND

Pre-IND Pre-IND

Preclinical in progress

Pre-IND

Pre-IND Pre-IND

Phase 1 not started

Pre-IND

Pre-IND Pre-IND

Phase 2 not started

Pre-IND

Pre-IND Pre-IND

Phase 3 not started

Pre-IND